Biotech Healthcare

Biotech Healthcare We believe in Innovation and Technology to bring the best Medical Solutions to you.

Biotech Group is specialized in the design; manufacture and marketing of medical implant devices for ophthalmology, and is focused on hyaluronic acid based medical implants for various specialties. By combining research and technology, Biotech Group innovates for ophthalmic surgery, for osteoarthritis treatment, and for skin rejuvenation by launching high quality health products in global markets.

25/03/2026

OPTIFLEX XTENSE. Full Visual Range EDOF IOL
See the World โ€“ Brazil

Travelling the world, admire colors and contrast nuances, at all distances, far, intermediate and near. Without the need of reading glasses.
Enjoy colors and contrast at any distance without disturbing glare or halos*

OPTIFLEX XTENSE Comfort Plus represents a major revolution in cataract outcomes and presbyopia correction. A hydrophobic EDOF intraocular lens with purely refractive optic, OPTIFLEX XTENSE delivers a continuous full visual range, from distance to intermediate to true near vision. Expanded visual range, minimal compromise and maximum clarity.



* Similar to monofocal IOLs

20/03/2026

๐€๐ˆ๐Ž๐‚ ๐Ÿ๐ŸŽ๐Ÿ๐Ÿ” ๐ข๐ง ๐‰๐š๐ข๐ฉ๐ฎ๐ซ has been a fantastic congress for us for many great reasons. We are particularly proud to ๐จ๐Ÿ๐Ÿ๐ข๐œ๐ข๐š๐ฅ๐ฅ๐ฒ ๐ฅ๐š๐ฎ๐ง๐œ๐ก ๐ข๐ง ๐ˆ๐ง๐๐ข๐š, one of our most expected innovations: ๐Ž๐ฉ๐ญ๐ข๐Ÿ๐ฅ๐ž๐ฑ ๐—๐“๐„๐๐’๐„ ๐‚๐จ๐ฆ๐Ÿ๐จ๐ซ๐ญ ๐๐ฅ๐ฎ๐ฌ, ๐ญ๐ก๐ž ๐Ÿ๐ฎ๐ฅ๐ฅ ๐ฏ๐ข๐ฌ๐ข๐จ๐ง ๐ซ๐š๐ง๐ ๐ž ๐„๐ƒ๐Ž๐… ๐ˆ๐Ž๐‹ ๐ญ๐ก๐š๐ญ ๐œ๐จ๐ซ๐ซ๐ž๐œ๐ญ๐ฌ ๐ฉ๐ซ๐ž๐ฌ๐›๐ฒ๐จ๐ฉ๐ข๐š. We were honoured during the launch by the precious presence of ๐ƒ๐ซ ๐’๐ซ๐ข ๐†๐š๐ง๐ž๐ฌ๐ก, ๐ƒ๐ซ ๐ƒ. ๐‘๐š๐ฆ๐š๐ฆ๐ฎ๐ซ๐ญ๐ก๐ฒ, ๐ƒ๐ซ ๐Š. ๐. ๐Š๐ฎ๐๐ฅ๐ฎ, ๐ƒ๐ซ ๐’๐ฎ๐ก๐š๐ฌ ๐‡๐š๐ฅ๐๐ข๐ฉ๐ฎ๐ซ๐ค๐š๐ซ ๐š๐ง๐ ๐ƒ๐ซ ๐“๐š๐ง๐ฏ๐ข ๐‡๐š๐ฅ๐๐ข๐ฉ๐ฎ๐ฅ๐ค๐š๐ซ. Interest shown in Optiflex XTENSE has completely fulfilled our expectations.

A special thank you to all doctors who have participated in our events and activities, our hands-on training program on loading and implantation of ๐„๐˜๐„๐‚๐‘๐˜๐‹ ๐๐ก๐š๐ค๐ข๐œ ๐ˆ๐Ž๐‹ ๐š๐ญ ๐จ๐ฎ๐ซ ๐จ๐ง-๐›๐จ๐จ๐ญ๐ก ๐„๐ฑ๐ฉ๐ž๐ซ๐ข๐ž๐ง๐œ๐ž ๐‹๐š๐›, ๐ญ๐ก๐ž ๐‚๐จ๐Ÿ๐Ÿ๐ž๐ž ๐ฐ๐ข๐ญ๐ก ๐ญ๐ก๐ž ๐„๐ฑ๐ฉ๐ž๐ซ๐ญ๐ฌ ๐’๐ž๐ฌ๐ฌ๐ข๐จ๐ง๐ฌ, ๐‹๐ข๐ฏ๐ž ๐ˆ๐ง๐ญ๐ž๐ซ๐ฏ๐ข๐ž๐ฐ๐ฌ ๐š๐ง๐ ๐จ๐ฎ๐ซ ๐’๐ฒ๐ฆ๐ฉ๐จ๐ฌ๐ข๐ฎ๐ฆ ๐จ๐ง ๐ฉ๐ซ๐ž๐ฆ๐ข๐ฎ๐ฆ ๐ˆ๐Ž๐‹๐ฌ.

Thank you to all members of the Biotech team for once again doing such a great job.

11/03/2026

Comparative Study Demonstrates EYECRYLโ„ข SERT Superior Intermediate Outcomes vs TECNIS Eyhance

A prospective comparative clinical study evaluating Eyecryl SERT and TECNIS Eyhance has been published (Cureus, January 2026), demonstrating Key 6-Month Findings:

1. Superior binocular and monocular intermediate visual acuity (66 cm), statistically significant (p < 0.0001)
2. Superior contrast sensitivity across all tested spatial frequencies
3. Higher reading speeds at both near and intermediate distances
4. Significant advantage at intermediate defocus levels
5. No adverse events or PCO observed during follow-up

Results do not only demonstrate strong intermediate acuity at the standardized 66 cm testing distance, but a broader intermediate functional benefit in defocus analysis โ€” supporting modern task-oriented vision. For surgeons seeking evidence-based differentiation in the EDOF category,
these findings definitely provide clinically relevant comparative data.
As patient expectations increasingly center around functional intermediate performance, published head-to-head outcomes become critical in lens selection strategy.
(Source: Comparative clinical study, Cureus 2026)

Read the whole study in the following link
https://biotechhealthcare.com/wp-content/uploads/2026/01/Eyecryl-Sert-Publication.pdf

09/03/2026

World Glaucoma Week is a global initiative organized by the World Glaucoma Association to raise awareness about glaucoma.
Glaucoma is one of the leading causes of preventable blindness.

At the current time (2025) there are about 80 million people worldwide with glaucoma. By the year 2040, it is estimated that 22 million individuals worldwide will be blind from glaucoma.
Most people with glaucoma are not aware of it: most glaucoma patients have zero symptoms.

The goal is to alert everyone to have regular eye and optic nerve checks to detect glaucoma as early as possible because there are available treatments for all forms of glaucoma to prevent visual loss.
Early diagnosis is key to slow down the irreversible damage caused by glaucoma. Catch the disease early and you have a great chance of preserving your vision for the years to come.

Make sure to have an eye exam regularly!

08/03/2026

International Womenโ€™s Day (IWD), celebrated annually on March 8th, honors the achievements of women across all aspects of life - social, economic, cultural, and political - while also advocating for gender equality.

International Womenโ€™s Day is a day to also remember that there is still a long way to go in terms of gender equality & inclusion. At Biotech Healthcare we support the empowering of women, as part of our vision.


A quick glimpse at our programmed activities during AIOS Conference at the JECC: - Product Launch- EYECRYL Phakic Experi...
05/03/2026

A quick glimpse at our programmed activities during AIOS Conference at the JECC:

- Product Launch
- EYECRYL Phakic Experience Lab
- Coffee with Experts Sessions
- Satellite Symposium

All details of our extensive program soon in our local social medial.
Stay tuned!

Donโ€™t miss them out! Looking forward to seeing you all at the AIOC 2026!

at Jaipurโ€™s JECC.
Visit us at our stand, BOOTH A106.

04/03/2026

Welcome to Jaipur!
Welcome to the AIOC 2026!

We are delighted to announce our presence at the AIOC with an exciting scientific program.

We will be very happy to share with you all our programmed activities: symposium, EYECRYL Phakic experience lab, and, especially, donโ€™t miss out our Product Launch, a groundbreaking innovation!

Looking forward to seeing you all at the AIOC 2026!

28/02/2026

BIO-HYALUR LVD is a viscoelastic solution, both cohesive and dispersive,
for depth chamber maintenance and excellent protection of the endothelium. BIO-HYALUR LVD is indicated for use whenever protection and lubrication of delicate cells of tissues are needed in anterior segment procedures including cataract extraction and intraocular lens implantation.
Optimal balance of viscosity and elasticity to support surgical precision Dual-action formula (HA+ CS) ensures chamber stability and endothelial
protection Low postoperative IOP rise - minimizing spikes and enhancing recovery comfort Predictable handling under varied flow rates - even in complex cataract cases Trusted in clinical settings for safety. efficacy. and controlled cell loss

To know more about Bio-Hyalur LVD please click on the following link:
https://biotechhealthcare.com/products/bio-hyalur-lvd/

* Store between 8ยบ C to 25ยบ C. Do not freeze. Protect from light.

25/02/2026

OPTIFLEX XTENSE outstanding features:

- Continuous Full Visual Range, Truly uninterrupted vision
- From true near vision to intermediate, to far
- Unparalleled independence from glasses across all distances
- High-Definition Visual Acuity: crisp vision, enhanced contrast, vibrant color

A small step for you, a giant leap for your patients.

Learn all about Optiflex XTENSE Comfort Plus at:
https://biotechhealthcare.com/products/optiflex-xtense-comfort-plus/

23/02/2026

OPTIFLEX XTENSE. Full Visual Range EDOF IOL
See the World โ€“ Madrid (Spain)

Travelling the world, admiring all the details from far to intermediate to true near
Vision, without the need of reading glasses.

OPTIFLEX XTENSE Comfort Plus represents a major revolution in cataract outcomes and presbyopia correction. A hydrophobic EDOF intraocular lens with purely refractive optic, OPTIFLEX XTENSE delivers a continuous full visual range, from distance to intermediate to true near vision. Expanded visual range, minimal compromise and maximum clarity.

Adresse

Obergrundstrasse 17, 6002 Luzern
Lucerne
6003

ร–ffnungszeiten

Montag 09:00 - 17:30
Dienstag 09:00 - 17:30
Mittwoch 09:00 - 17:30
Donnerstag 09:00 - 17:30
Freitag 09:00 - 17:30
Samstag 09:00 - 17:30

Webseite

Benachrichtigungen

Lassen Sie sich von uns eine E-Mail senden und seien Sie der erste der Neuigkeiten und Aktionen von Biotech Healthcare erfรคhrt. Ihre E-Mail-Adresse wird nicht fรผr andere Zwecke verwendet und Sie kรถnnen sich jederzeit abmelden.

Die Praxis Kontaktieren

Nachricht an Biotech Healthcare senden:

Verknรผpfungen

Teilen

Share on Facebook Share on Twitter Share on LinkedIn
Share on Pinterest Share on Reddit Share via Email
Share on WhatsApp Share on Instagram Share on Telegram

Kategorie

Our Story

Biotech Healthcare Group, founded in 1999, manufactures and supplies a range of products in Ophthalmology, Dermatology, Orthopaedics & Urology verticals. We are one of the leading manufacturers and suppliers of intraocular lenses, ophthalmic solutions and diagnostic range of equipment for eye care industry with production capacity of over 2.4 million lenses per year.

With our sales and marketing Headquarters in Luzern, Switzerland, we have established research & development centers with state-of-the-art manufacturing facilities in Roscommon, Ireland and Ahmedabad, India. Today, our products reach in more than 90 countries including Europe, South America, Middle East, South-East Asia and SAARC Nations.

Our people at Biotech come from divergent backgrounds and experiences. Our common goal, urge for innovation, passion for developing high quality products & commitment towards customer service helps us to move every step closer towards serving people for a better life.